Kilitch Drugs
add_icon

Kilitch Drugs

315.40
-0.70
(-0.22%)
Market Cap
551.34 Cr
PE Ratio
22.17
Volume
51,253.00
Day High - Low
325.00 - 312.35
52W High-Low
500.00 - 293.53
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
551.34 Cr
EPS
16.60
PE Ratio
22.17
PB Ratio
2.07
Book Value
151.97
EBITDA
42.60
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
12.44
Debt to Equity
0.21
Analyst Rating and Forecast
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Kilitch Drugs (India) Limited conducted an Extra-Ordinary General Meeting on March 13, 2026, to approve authorized capital increase and 1:1 bonus share issue through video conferencing.
positive
Kilitch Drugs (India) Limited schedules EGM for March 13, 2026 to increase authorized capital from ₹25 crore to ₹40 crore and approve 1:1 bonus share issue.
neutral
Kilitch Drugs (India) Limited submitted its monitoring agency report for Q3FY26 under SEBI regulations, showing Rs. 22.05 crore utilization towards Greenfield project with no deviations reported.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,767.10
#1 4,23,986.48
38.94
#1 54,729.00
9.71
#1 10,980
16.07
53.49
6,024.00
1,59,918.27
65.35
9,712.00
18.67
2,191
-1.02
43.80
4,207.20
1,42,390.77
63.57
11,539.40
6.99
1,911
26.24
50.03
2,308.30
1,05,442.87
22.73
22,909.50
13.74
3,306
#1 37.44
56.84
1,258.70
1,05,054.92
19.63
33,741.20
16.73
5,725
-15.28
53.38
1,226.00
99,032.82
22.38
28,409.50
7.12
5,291
-57.18
31.85
863.10
86,848.06
#1 17.83
23,511.00
18.55
4,615
-0.32
45.58
1,920.90
79,295.73
45.78
12,744.20
#1 20.90
2,007
7.65
37.22
1,279.90
74,336.80
21.52
32,345.60
9.43
3,484
7.59
60.75
5,131.50
61,354.78
25.95
13,458.30
3.70
2,216
1.90
37.74
Growth Rate
Revenue Growth
31.84 %
Net Income Growth
83.09 %
Cash Flow Change
1,246.41 %
ROE
60.93 %
ROCE
20.31 %
EBITDA Margin (Avg.)
12.87 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
31
29
9
19
12
16
17
13
11
19
21
21
21
24
36
37
34
31
31
47
37
42
35
45
36
53
58
63
46
56
55
Expenses
25
22
12
16
11
14
14
14
11
15
17
20
19
20
34
32
30
27
26
39
30
33
30
38
32
41
47
47
40
44
48
EBITDA
6
6
-3
2
1
2
2
-1
-1
3
3
2
2
4
2
5
4
4
5
7
7
9
5
8
4
11
11
16
6
12
8
Operating Profit %
11 %
17 %
-42 %
15 %
-7 %
11 %
10 %
-20 %
-11 %
16 %
15 %
2 %
5 %
16 %
2 %
14 %
10 %
13 %
13 %
14 %
17 %
21 %
7 %
16 %
5 %
13 %
16 %
24 %
8 %
10 %
11 %
Depreciation
1
1
1
1
0
0
1
1
1
1
1
1
0
1
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
1
1
2
2
2
1
2
0
1
2
2
1
1
Profit Before Tax
5
6
-4
1
0
2
2
-2
-2
3
3
1
1
3
2
4
3
2
3
5
5
7
3
5
2
10
8
14
4
9
6
Tax
1
2
1
1
0
0
1
-0
-0
1
1
1
1
0
1
1
1
-0
1
2
2
2
1
2
2
2
3
4
1
1
1
Net Profit
4
4
-5
1
-0
1
1
-1
-1
2
2
1
1
3
1
2
2
2
2
3
3
5
2
4
0
9
6
10
2
8
4
EPS in ₹
2.87
3.01
-3.33
0.30
-0.13
0.87
0.62
-0.81
-0.86
1.34
1.43
0.46
0.76
1.39
0.72
1.86
1.34
1.56
1.52
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
2.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
127
117
113
128
144
143
203
210
220
240
313
Fixed Assets
9
42
33
33
32
32
30
65
64
62
64
Current Assets
47
47
49
63
65
56
80
114
126
146
174
Capital Work in Progress
0
0
1
3
20
30
66
3
4
6
47
Investments
25
23
53
56
53
52
60
71
62
72
72
Other Assets
93
51
26
35
38
30
47
71
90
100
129
Total Equity & Liabilities
127
117
113
128
144
143
203
210
220
240
313
Current Liabilities
7
8
12
15
20
22
73
69
69
64
84
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
28
Total Equity
120
109
101
113
123
121
130
140
151
176
201
Reserve & Surplus
107
96
88
96
106
103
112
121
131
160
186
Share Capital
13
13
13
14
15
15
16
16
16
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-39
-2
-0
3
3
-5
10
-2
10
-1
-9
Investing Activities
-31
-20
-2
-4
-14
-10
-38
-15
8
-8
-40
Operating Activities
-8
17
1
1
0
5
46
6
3
-2
18
Financing Activities
-0
0
0
6
17
1
2
7
-1
9
13

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
68.63 %
68.33 %
68.33 %
68.25 %
68.25 %
68.25 %
68.25 %
68.25 %
68.25 %
68.25 %
69.23 %
69.23 %
69.23 %
69.23 %
69.23 %
69.23 %
69.23 %
69.23 %
63.77 %
63.77 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.65 %
27.41 %
27.67 %
27.28 %
27.58 %
27.73 %
27.60 %
27.52 %
27.49 %
27.40 %
26.13 %
26.13 %
25.37 %
25.21 %
25.10 %
25.74 %
25.57 %
25.54 %
30.22 %
31.04 %
Others
3.72 %
4.26 %
3.99 %
4.48 %
4.17 %
4.02 %
4.15 %
4.23 %
4.27 %
4.36 %
4.63 %
4.64 %
5.39 %
5.56 %
5.67 %
5.02 %
5.20 %
5.23 %
6.01 %
5.18 %
No of Share Holders
9,756
9,214
8,740
9,129
9,133
9,209
9,380
9,435
9,522
9,573
9,002
9,062
9,525
9,620
9,920
10,139
9,749
10,379
10,929
12,043

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.5 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements

Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20155 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report9 days ago
Shareholder Meeting / Postal Ballot-Outcome of EGM9 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Notice Of EGMFeb 16, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Board Meeting Outcome for Outcome Of Board MeetingFeb 11, 2026
Financial Results For The Quarter Ended 31St December 2025Feb 11, 2026
Board Meeting Intimation for Considering And Approval Unaudited Quarterly Financial Results For The Quarter Ended 31St December 2025 Bonus Issue Increase Authorised Capital Convene EGM Finalise Record DateFeb 04, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2026
Closure of Trading WindowDec 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Monitoring Agency ReportNov 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 13, 2025
Unaudited Financial Results For The Quarter Ended 30Th September 2025Nov 13, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Statement Of The Company For The Quarter Ended 30Th September 2025Nov 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Letter To Shareholders - Annual Report For FY 2024-25Sep 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Book Closure IntimationSep 01, 2025
Notice Of Annual General MeetingSep 01, 2025
Reg. 34 (1) Annual Report.Sep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
Postponement Of Credit Of Right Issue And Listing Of SharesAug 25, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 25, 2025
Postponement In Finalization Of Basis Of Allotment And Allotment Schedule For Rights IssueAug 22, 2025
Financial Results For Quarter Ended 30Th June 2025Aug 13, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 13, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial ResultsAug 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Corporate Action-Outcome of Right issueJul 12, 2025
Corrigendum To Outcome Of Board Meeting Held On July 12 2025Jul 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Scheduled To Approve Issue Period And Letter Of OfferJul 12, 2025
Intimation Of Record DateJul 09, 2025
Board Meeting Outcome for Outcome Of Board MeetingJul 09, 2025
Board Meeting Outcome for Outcome Of Board MeetingJul 02, 2025
Closure of Trading WindowJun 29, 2025
Board Meeting Intimation for Considering And Approval Of The Proposal For Fund Raising By Way Of Issue Of Equity Shares Through Right Issue And Any Other BusinessesJun 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 22, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Financial ResultsMay 19, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 19, 2025
Board Meeting Intimation for Considering And Approving Standalone And Consolidated Quarterly Financial Results For The Period Ended 31St March 2025May 13, 2025

Technical Indicators

RSI(14)
Neutral
45.23
ATR(14)
Less Volatile
12.89
STOCH(9,6)
Neutral
40.06
STOCH RSI(14)
Neutral
56.59
MACD(12,26)
Bullish
0.53
ADX(14)
Weak Trend
8.55
UO(9)
Bearish
45.40
ROC(12)
Uptrend And Accelerating
1.14
WillR(14)
Neutral
-59.40